1. Home
  2. MDCX vs MFC Comparison

MDCX vs MFC Comparison

Compare MDCX & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDCX
  • MFC
  • Stock Information
  • Founded
  • MDCX 2008
  • MFC 1887
  • Country
  • MDCX Canada
  • MFC Canada
  • Employees
  • MDCX N/A
  • MFC N/A
  • Industry
  • MDCX
  • MFC Life Insurance
  • Sector
  • MDCX
  • MFC Finance
  • Exchange
  • MDCX Nasdaq
  • MFC Nasdaq
  • Market Cap
  • MDCX 48.4M
  • MFC 49.3B
  • IPO Year
  • MDCX N/A
  • MFC 1999
  • Fundamental
  • Price
  • MDCX $3.96
  • MFC $30.14
  • Analyst Decision
  • MDCX Strong Buy
  • MFC Strong Buy
  • Analyst Count
  • MDCX 2
  • MFC 2
  • Target Price
  • MDCX $12.00
  • MFC $45.50
  • AVG Volume (30 Days)
  • MDCX 53.5K
  • MFC 2.7M
  • Earning Date
  • MDCX 01-01-0001
  • MFC 05-07-2025
  • Dividend Yield
  • MDCX N/A
  • MFC 3.99%
  • EPS Growth
  • MDCX N/A
  • MFC 8.81
  • EPS
  • MDCX N/A
  • MFC 1.97
  • Revenue
  • MDCX N/A
  • MFC $20,844,569,236.00
  • Revenue This Year
  • MDCX N/A
  • MFC $41.78
  • Revenue Next Year
  • MDCX N/A
  • MFC $7.54
  • P/E Ratio
  • MDCX N/A
  • MFC $15.31
  • Revenue Growth
  • MDCX N/A
  • MFC 10.08
  • 52 Week Low
  • MDCX $1.80
  • MFC $22.96
  • 52 Week High
  • MDCX $4.99
  • MFC $33.07
  • Technical
  • Relative Strength Index (RSI)
  • MDCX N/A
  • MFC 52.44
  • Support Level
  • MDCX N/A
  • MFC $28.13
  • Resistance Level
  • MDCX N/A
  • MFC $29.25
  • Average True Range (ATR)
  • MDCX 0.00
  • MFC 1.24
  • MACD
  • MDCX 0.00
  • MFC 0.08
  • Stochastic Oscillator
  • MDCX 0.00
  • MFC 62.58

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

About MFC Manulife Financial Corporation

Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.

Share on Social Networks: